Fifth Third Bancorp’s Health Catalyst HCAT Stock Holding History

Fifth Third Bancorp’s Portfolio HCAT Stock Details HCAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$60	Sell	30 -28	-48%	-$40	﹤0.01%	4316
2026 Q1	$74	Hold	58	–	–	﹤0.01%	4273
2025 Q4	$139	Hold	58	–	–	﹤0.01%	2610
2025 Q3	$165	Sell	58 -34	-37%	-$116	﹤0.01%	2644
2025 Q2	$347	Buy	+92	New	+$362	﹤0.01%	2514
2022 Q2	–	Sell	-1,565	Closed	-$41K	–	2709
2022 Q1	$41K	Hold	1,565	–	–	﹤0.01%	1538
2021 Q4	$62K	Hold	1,565	–	–	﹤0.01%	1422
2021 Q3	$78K	Hold	1,565	–	–	﹤0.01%	1263
2021 Q2	$87K	Hold	1,565	–	–	﹤0.01%	1238
2021 Q1	$73K	Hold	1,565	–	–	﹤0.01%	1271
2020 Q4	$68K	Hold	1,565	–	–	﹤0.01%	1263
2020 Q3	$57K	Buy	+1,565	New	+$53.1K	﹤0.01%	1288

Other funds holding HCAT

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

CDC Financial Chicago, Illinois $239M AUM

PVM

Palogic Value Management Dallas, Texas $304M AUM 15.15% 1-Year Est. Return

Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return

Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fifth Third Bancorp's HCAT Position: Q2 2026 in Review

Fifth Third Bancorp reduced its Health Catalyst (HCAT) stake by 48% in Q2 2026, selling an estimated $40 and leaving 30 shares worth $60. The position accounts for ﹤0.01% of the portfolio, ranked #4316.

Fifth Third Bancorp first reported a position in HCAT in Q3 2020 and has held it in 12 quarters since. The position peaked at $87K in Q2 2021. 127 funds tracked by Wall St. Rank hold HCAT as of Q2 2026.

Fifth Third Bancorp held 30 shares of Health Catalyst worth $60 as of Q2 2026.
Fifth Third Bancorp sold 28 Health Catalyst shares in Q2 2026, an estimated $40.
Health Catalyst made up ﹤0.01% of Fifth Third Bancorp's portfolio in Q2 2026, its #4316 holding.
Fifth Third Bancorp first reported a position in Health Catalyst in Q3 2020 and has held it in 12 quarters since.
Fifth Third Bancorp's Health Catalyst position peaked at $87K in Q2 2021.
127 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2026.

Based on Fifth Third Bancorp's 13F filing for Q2 2026, filed 5 Aug 2026.